SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-024420
Filing Date
2022-02-16
Accepted
2022-02-16 21:10:11
Documents
1
Period of Report
2022-01-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm226968-1_4a.html 4/A  
1 OWNERSHIP DOCUMENT tm226968-1_4a.xml 4/A 8606
  Complete submission text file 0001104659-22-024420.txt   10177
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-32587 | Film No.: 22645429